Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

159.64
+2.701.72%
Post-market: 160.100.4600+0.29%17:48 EDT
Volume:2.94M
Turnover:467.52M
Market Cap:247.60B
PE:23.90
High:160.30
Open:157.68
Low:157.23
Close:156.94
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.82
T/O Rate:0.20%
Dividend:3.17
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.92
PE(LYR):24.41

Loading ...

AstraZeneca Q2 Adj. EPS $2.63 Beats $2.48 Estimate, Sales $15.384B Miss $15.459B Estimate

Benzinga Earnings
·
Jul 27

AstraZeneca Beats Second-Quarter Profit Expectations, Holds Outlook

Reuters
·
Jul 27

Movement Alert|AstraZeneca PLC Rises 5.33% Overnight, Q2 Earnings Beat Market Expectations

Market Focus
·
Jul 27

Astrazeneca Q2 Revenue Rises 6% on Demand for Its Cancer Therapies

Reuters
·
Jul 27

Astrazeneca PLC Stock Rises Friday, Underperforms Market

Dow Jones
·
Jul 25

Astrazeneca's Drug Pipeline in Focus After Recent Trial Miss

Dow Jones
·
Jul 24

AstraZeneca, Daiichi Sankyo's Enhertu Combination Therapy Recommended for EU Approval in Breast Cancer

MT Newswires Live
·
Jul 24

AstraZeneca's Trixeo Recommended for EU Approval to Treat Asthma

MT Newswires Live
·
Jul 24

AstraZeneca, Daiichi’s Enhertu with pertuzumab recommended for approval in EU

TIPRANKS
·
Jul 24

AstraZeneca announces Trixeo Aerosphere recommended for approval in EU

TIPRANKS
·
Jul 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Jul 24

Astrazeneca PLC Expected to Post Earnings of $2.54 a Share - Earnings Preview

Reuters
·
Jul 24

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Amid Major Tech Stocks Sell-Off

MT Newswires Live
·
Jul 23

AstraZeneca announces Etcamah with CDK4/6 inhibitor approved in EU

TIPRANKS
·
Jul 23

Astrazeneca's Etcamah combination for ESR1-mutated advanced breast cancer

MT Newswires Live
·
Jul 23

European Union Grants Approval to AstraZeneca's New Breast Cancer Medication

Stock News
·
Jul 23

Astrazeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug

MT Newswires Live
·
Jul 22

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 22